Walter M. Stadler to Thyroid Neoplasms
This is a "connection" page, showing publications Walter M. Stadler has written about Thyroid Neoplasms.
Connection Strength
0.157
-
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer. Ann Oncol. 2023 08; 34(8):714-722.
Score: 0.157